Welcome
Support Centre
11 October 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Which mask for facial oxygen at awake caesarean section?
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN60326156
Date ISRCTN assigned30/09/2005
Local reference number(s)N0436160509
Public titleWhich mask for facial oxygen at awake caesarean section?
Scientific title
AcronymN/A
Disease/condition/study domainPregnancy and Childbirth: Anaesthesia
Study hypothesisThe aim of this study is to determine the efficiency of Hudson and Rebreathing oxygen facial mask in terms of fetal oxygen delivery
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaTo enrol the patient requiring elective caesarean section under regional anaesthesia.
Participants - exclusion criteria1. ASA III
2. Failure to attain the level of block (touch to T5)
3. Any intravenous analgesia or anaesthesia are given before the birth of the child
Patient information material
Anticipated start date01/12/2004
Anticipated end date01/05/2005
Status of trialCompleted
Target number of participantsTotal Target Recruitment: 40
InterventionsRandomised controlled trial
Primary outcome measure(s)The oxygen of umbilical vein, and umbilical artery blood result observations are made by an independent observer (which is a routine procedure).
Secondary outcome measure(s)See Primary outcome measures
Sources of fundingLeeds Teaching Hospitals NHS Trust

NHS R&D Support Funding
Sponsor nameRecord Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Sponsor detailsThe Department of Health, Richmond House, 79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.dh.gov.uk/Home/fs/en
Contact nameDr Gordon Lyons
Contact detailsLabour Ward
Level 5
Gledhow Wing
Beckett Street
Leeds
United Kingdom
LS9 7TF
Contact telephone+44 (0)113 206 5371 ext. 5371
Contact fax+44 (0)113 242 6496
Contact emailGordon.Lyons@leedsth.nhs.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN60326156
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central